Type II Glycoengineered Anti-CD20 Antibody MIL62 or Cyclosporine in Chinese Primary Membranous Nephropathy: A Multicenter, Randomized, Open-Label Phase 1b/2 Trial

Authors: Zhao Cui, Zhang Yimiao, Heng Li, Hua Zhou, Hong Li Lin, Guangqun Xing, Wei Chen, Wei Liang, Ping Luo, Chen Xiao Lan, Hui Xu, Yan Zha, Yue Wang, Xing Chen, Zhaohui Ni, Junjun Zhang, Wanhong Lu, Li Hua Zhang, Ming-Hui Zhao, Min Wei, Song Meng, Liang Jinjin, Feng Li

Published: 2024-10-28

DOI: 10.1681/asn.2024yaqz098x

Keywords: No keywords found.

Abstract:
No abstract found.

Source: